Nasal Vaccines May Provide Additional Immune Support Against Respiratory Viruses


Immune B cells secrete immunoglobin A antibodies that work on mucosal surfaces in the nose, stomach, and lungs.

Intranasal vaccination may provide broad-based protection against heterologous respiratory viruses based on early results in mice, whereas injection-based vaccination did not have the same effect, according to a study published in Science Immunology.

Mucus membranes have a unique defense system for combatting airborne or foodborne pathogens. Immune B cells secrete immunoglobin A (IgA) antibodies, which work locally on mucosal surfaces in the nose, stomach, and lungs. The investigators sought to establish whether triggering IgA response might also produce a localized immune response against respiratory viruses.

“The best immune defense happens at the gate, guarding against viruses trying to enter,” said Akiko Iwasaki, PhD, the Waldemar Von Zedtwitz Professor of Immunobiology at Yale, in a press release

To conduct the study, investigators tested a protein-based vaccine designed to jump start an IgA immune response. This vaccine was administered to mice, either intramuscularly or intranasally.

These mice were then exposed to multiple strains of influenza viruses. According to the investigators, the mice that received intranasal vaccination were significantly better protected against respiratory influenza than those who received injections.

Further, these nasal vaccines induced antibodies that protected the mice against a variety of flu strains, not just against the strain the vaccine was meant to protect against. This was not observed in the population that received the vaccine through a shot.

Currently, the investigators are testing nasal vaccine strains against COVID-19 in animal models. Although both the vaccine injections and nasal vaccines increased levels of antibodies in the blood of the mice, only the nasal vaccine enabled IgA secretion into the lungs.

If these nasal vaccines are proven safe and efficient in humans, the investigators said they expect them to be used in conjunction with existing vaccines and boosters that work system wide. This method would allow the body to add immune system support at the source of infection, according to the study.


Nasal vaccine may aid fight against new viral variants [news release]. EurekAlert; December 10, 2021. Accessed December 13, 2021.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.